Villa Garda Hospital
Garda, Verona, 37016, Italy
NCT Number: NCT01611220
Anorexia Nervosa inpatient treatment has often a short-term success as weight is restored to a healthy level, but high percentage of patients relapse during the first year following the discharge. The development of strategies to overcome this problem represents a priority for clinicians. Aim of this trial is to evaluate the effects of a relapse prevention program based on cognitive dissonance theory developed for hospitalized patients.
Looking for future studies?
Notify Me13 year–65 year
Female
Interventional
Not applicable
Garda, Verona, 37016, Italy
Inpatient treatment for anorexia nervosa is often successful in restoring body weight, but a high percentage of patients relapse following discharge. The aim of the study was to assess the effect of a relapse prevention program during the last phase of inpatient treatment. Patients, when they achieve a BMI of 18.5, are randomly allocated to complete the standard cognitive behavior inpatient treatment (CBT-I) or to complete the standard CBT-I plus eight relapse prevention groups based on the cognitive dissonance. The intervention has been derived by the selective and indicated prevention programs using a dissonance-based approach. This intervention showed to be effective in reducing the risk for eating pathology onset. The primary outcome of the study is to assess the number of patients allocated to the two condition with a BMI equal or greater than 18.5 at 12-months after discharge.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The dissonance relapse prevention intervention consists of eight groups conducted by a psychologist who involves participants in interactive activities aimed to prevent relapse after discharge from the inpatient treatment
Other names: Dissonance relapse prevention
Time frame: 1 year
The main outcome is to assess the number of patients with good BMI outcome (BMI ≥ 18.5) at 12-month follow-up end in the two arm conditions.
Time frame: 1 year
Number of patients with "full remission" defined as having a global EDE score below 1SD above the community mean (1.74) and a BMI ≥ 18.5.
Looking for future studies?
Notify MeVilla Garda Hospital
Other
Dissonance Inpatient Relapse Prevention Program for Anorexia Nervosa: A Randomized Control Trial
Acronym: RePAN
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06085092
Anorexia Nervosa, Eating Disorders
Hershey, Pennsylvania, United States
View Trial DetailsNCT02381639
Anorexia Nervosa, Feeding and Eating Disorders
Nantes, France
View Trial DetailsNCT07098156
Anorexia Nervosa, Autism
Aberdeen, Aberdeen City, United Kingdom
View Trial DetailsNCT05596799
Anorexia Nervosa, Anorexia Nervosa in Remission
Louisville, Kentucky, United States
View Trial Details